These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22539806)

  • 1. Plasma prolylcarboxypeptidase (angiotensinase C) is increased in obesity and diabetes mellitus and related to cardiovascular dysfunction.
    Xu S; Lind L; Zhao L; Lindahl B; Venge P
    Clin Chem; 2012 Jul; 58(7):1110-5. PubMed ID: 22539806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolylcarboxypeptidase gene expression in the heart and kidney: Effects of obesity and diabetes.
    Tabrizian T; Hataway F; Murray D; Shariat-Madar Z
    Cardiovasc Hematol Agents Med Chem; 2015; 13(2):113-23. PubMed ID: 26362276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolyl carboxypeptidase activity in the circulation and its correlation with body weight and adipose tissue in lean and obese subjects.
    Kehoe K; Noels H; Theelen W; De Hert E; Xu S; Verrijken A; Arnould T; Fransen E; Hermans N; Lambeir AM; Venge P; Van Gaal L; De Meester I
    PLoS One; 2018; 13(5):e0197603. PubMed ID: 29772029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolylcarboxypeptidase (PrCP) inhibitors and the therapeutic uses thereof: a patent review.
    Graham TH
    Expert Opin Ther Pat; 2017 Oct; 27(10):1077-1088. PubMed ID: 28699813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Prolylcarboxypeptidase Expression and Function in Response to Different Risk Factors of Diabetes.
    Tabrizian T; Floyd L; Shariat-Madar Z
    Cardiovasc Hematol Agents Med Chem; 2017; 14(3):175-189. PubMed ID: 28034286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a specific prolylcarboxypeptidase activity assay and its suitability for plasma and serum measurements.
    Kehoe K; Verkerk R; Sim Y; Waumans Y; Van der Veken P; Lambeir AM; De Meester I
    Anal Biochem; 2013 Dec; 443(2):232-9. PubMed ID: 24036038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant prolylcarboxypeptidase activates plasma prekallikrein.
    Shariat-Madar Z; Mahdi F; Schmaier AH
    Blood; 2004 Jun; 103(12):4554-61. PubMed ID: 14996700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment.
    Shariat-Madar B; Kolte D; Verlangieri A; Shariat-Madar Z
    Diabetes Metab Syndr Obes; 2010 Apr; 3():67-78. PubMed ID: 20694162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of the renin-angiotensin system during lung ischemia-reperfusion injury.
    Kehoe K; Gielis JF; Vliegen G; Van Elzen R; Verkerk R; Driessens E; Domen A; Lambeir AM; Maes L; Cos P; De Meester I; Van Schil PE
    Exp Lung Res; 2016 Aug; 42(6):277-85. PubMed ID: 27437782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient prolylcarboxypeptidase gene and protein expression in left ventricles of spontaneously hypertensive rats (SHR).
    Marangoni RA; Santos RA; Piccolo C
    Peptides; 2014 Nov; 61():69-74. PubMed ID: 25218829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosis.
    Adams GN; LaRusch GA; Stavrou E; Zhou Y; Nieman MT; Jacobs GH; Cui Y; Lu Y; Jain MK; Mahdi F; Shariat-Madar Z; Okada Y; D'Alecy LG; Schmaier AH
    Blood; 2011 Apr; 117(14):3929-37. PubMed ID: 21297000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of prolylcarboxypeptidase (PrCP) inhibitors to validate PrCP as a potential target for obesity.
    Zhou C; Garcia-Calvo M; Pinto S; Lombardo M; Feng Z; Bender K; Pryor KD; Bhatt UR; Chabin RM; Geissler WM; Shen Z; Tong X; Zhang Z; Wong KK; Roy RS; Chapman KT; Yang L; Xiong Y
    J Med Chem; 2010 Oct; 53(19):7251-63. PubMed ID: 20857914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of prolylcarboxypeptidase enhances plasma prekallikrein activation on Chinese hamster ovary cells.
    Shariat-Madar Z; Rahimy E; Mahdi F; Schmaier AH
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2697-703. PubMed ID: 16113074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced levels of neurotransmitter-degrading enzyme PRCP promote a lean phenotype. [corrected].
    Palmiter RD
    J Clin Invest; 2009 Aug; 119(8):2130-3. PubMed ID: 19620779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis.
    Rabey FM; Gadepalli RS; Diano S; Cheng Q; Tabrizian T; Gailani D; Rimoldi JM; Shariat-Madar Z
    Curr Med Chem; 2012; 19(24):4194-206. PubMed ID: 22664251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, purification and crystallization of human prolylcarboxypeptidase.
    Abeywickrema PD; Patel SB; Byrne NJ; Diehl RE; Hall DL; Ford RE; Rickert KW; Reid JC; Shipman JM; Geissler WM; Pryor KD; SinhaRoy R; Soisson SM; Lumb KJ; Sharma S
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Jun; 66(Pt 6):702-5. PubMed ID: 20516604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cross-sectional Study of KLKB1 and PRCP Polymorphisms in Patient Samples with Cardiovascular Disease.
    Gittleman HR; Merkulova A; Alhalabi O; Stavrou EX; Veigl ML; Barnholtz-Sloan JS; Schmaier AH
    Front Med (Lausanne); 2016; 3():17. PubMed ID: 27200353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolylcarboxypeptidase independently activates plasma prekallikrein (fletcher factor).
    Wang J; Matafonov A; Madkhali H; Mahdi F; Watson D; Schmaier AH; Gailani D; Shariat-Madar Z
    Curr Mol Med; 2014; 14(9):1173-85. PubMed ID: 25324000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolylcarboxypeptidase: a cardioprotective enzyme.
    Mallela J; Yang J; Shariat-Madar Z
    Int J Biochem Cell Biol; 2009 Mar; 41(3):477-81. PubMed ID: 18396440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitors.
    Debenham JS; Graham TH; Verras A; Zhang Y; Clements MJ; Kuethe JT; Madsen-Duggan C; Liu W; Bhatt UR; Chen D; Chen Q; Garcia-Calvo M; Geissler WM; He H; Li X; Lisnock J; Shen Z; Tong X; Tung EC; Wiltsie J; Xu S; Hale JJ; Pinto S; Shen DM
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6228-33. PubMed ID: 24157366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.